New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 24, 2013
08:23 EDTNEPTNeptune Technologies obtains allowance of patent specific to krill oil
Neptune Technologies & Bioressources announces that the U.S. Patent & Trademark Office, or USPTO, has allowed a second continuation patent application, application number 13/545,830, which claims the benefit of prior Neptune U.S. Patents No. 8,030,348 and 8,278,351. This second continuation application contains only a single claim, which is directed to a capsule comprising an Antarctic krill oil extract comprising a phospholipid suitable for human consumption. This claim covers most, if not all, krill oil products presently sold in the U.S. market. This second continuation application, which was filed less than six months ago, was allowed by the USPTO after a thorough examination. During prosecution, Neptune provided the USPTO with all prior art references and other materials, including all the documents referred to in all of the re-examination requests filed by Aker Biomarine ASA directed to the '348 and '351 Patents, as well as all the documents relating to the oppositions currently underway on related Neptune patents in Europe and Australia.
News For NEPT From The Last 14 Days
Check below for free stories on NEPT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 17, 2014
10:11 EDTNEPTNeptune Technologies receives USPTO patent
Reference Link
July 15, 2014
17:56 EDTNEPTNeptune Technologies reports Q1 revenue C$3.64M vs. C$6.08M last year
Gross profit as a percent of revenue was 14% for the current quarter, versus 10% for the corresponding prior year quarter. Reports Q1 Adjusted EBITDA (C$3.77M) vs. (C$2.7M) in the prior year. Reports Q1 net loss (C$5.7M) vs. (C$3.38M) last year.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use